Cannabis finance news

Cann Group secures $750k funding via convertible note

by Adam Sheldon March 16, 2026June 8, 2026

Cann Group has secured $750,000 in funding through a convertible securities agreement with US-based investor Obsidian […]

Helius Therapeutics enters voluntary administration, shuts Auckland manufacturing facility

by Steve Jones March 11, 2026March 11, 2026

E-commerce surge lifts Elixinol margins in FY25 but losses deepen

by Adam Sheldon March 3, 2026March 5, 2026

‘Subdued prescriber activity’ blamed by Cann Group for revenue fall

by Steve Jones March 2, 2026March 5, 2026

Bioxyne lifts FY26 guidance after margin growth in strong first half

by Steve Jones February 26, 2026February 26, 2026

Vitura Health reports first-half loss as price war continues to hit margins

by Steve Jones February 25, 2026February 25, 2026

Nexalis outlines 2026 plan as IRX shares jump 35%

by Adam Sheldon February 17, 2026February 19, 2026

Cannim liquidator draws up timeframe for potential litigation and court-ordered director examinations

by Steve Jones February 10, 2026February 10, 2026

Tensions run high as creditors vote to wind up Cannim Group

by Steve Jones February 5, 2026February 5, 2026

Cannatrek ‘evolution’ key to merger, says LGP managing director

by Adam Sheldon February 3, 2026February 5, 2026